PL348156A1 - Pharmaceutical composition, containing fragments of an antigenic protein encoding dna endowed with anti-tumor effect - Google Patents
Pharmaceutical composition, containing fragments of an antigenic protein encoding dna endowed with anti-tumor effectInfo
- Publication number
- PL348156A1 PL348156A1 PL99348156A PL34815699A PL348156A1 PL 348156 A1 PL348156 A1 PL 348156A1 PL 99348156 A PL99348156 A PL 99348156A PL 34815699 A PL34815699 A PL 34815699A PL 348156 A1 PL348156 A1 PL 348156A1
- Authority
- PL
- Poland
- Prior art keywords
- endowed
- pharmaceutical composition
- encoding dna
- tumor effect
- antigenic protein
- Prior art date
Links
- 230000000259 anti-tumor effect Effects 0.000 title 1
- 230000000890 antigenic effect Effects 0.000 title 1
- 239000012634 fragment Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4727—Mucins, e.g. human intestinal mucin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A61K39/001136—Cytokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Mycology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT1998MI002330A IT1303683B1 (it) | 1998-10-30 | 1998-10-30 | Composizione farmaceutiche ad azione antitumorale contenente dnacodificante per frammenti di una proteina antigenica. |
PCT/EP1999/007874 WO2000025827A2 (en) | 1998-10-30 | 1999-10-18 | Dna molecules encoding muc-1 and use thereof in tumor vaccination |
Publications (1)
Publication Number | Publication Date |
---|---|
PL348156A1 true PL348156A1 (en) | 2002-05-06 |
Family
ID=11380969
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL99348156A PL348156A1 (en) | 1998-10-30 | 1999-10-18 | Pharmaceutical composition, containing fragments of an antigenic protein encoding dna endowed with anti-tumor effect |
Country Status (19)
Country | Link |
---|---|
EP (1) | EP1124956A2 (it) |
JP (1) | JP2002528519A (it) |
CN (1) | CN1324406A (it) |
AR (1) | AR020927A1 (it) |
AU (1) | AU1152200A (it) |
BG (1) | BG105458A (it) |
BR (1) | BR9914892A (it) |
CA (1) | CA2348745A1 (it) |
CO (1) | CO5231134A1 (it) |
CZ (1) | CZ20011521A3 (it) |
EA (1) | EA200100395A1 (it) |
HU (1) | HUP0103784A2 (it) |
IT (1) | IT1303683B1 (it) |
MX (1) | MXPA01004186A (it) |
PE (1) | PE20001287A1 (it) |
PL (1) | PL348156A1 (it) |
SK (1) | SK5712001A3 (it) |
TR (1) | TR200101141T2 (it) |
WO (1) | WO2000025827A2 (it) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6548643B1 (en) | 1994-11-16 | 2003-04-15 | Austin Research Institute | Antigen carbohydrate compounds and their use in immunotherapy |
WO2001057068A1 (en) * | 2000-02-01 | 2001-08-09 | The Austin Research Institute | Mucin-1 derived antigens and their use in immunotherapy |
JP5165175B2 (ja) * | 2000-09-11 | 2013-03-21 | デイナ ファーバー キャンサー インスティチュート,インコーポレイテッド | Muc1細胞外ドメインおよびそれから得られた癌治療組成物 |
JP4276432B2 (ja) | 2000-12-22 | 2009-06-10 | ダナ−ファーバー キャンサー インスティテュート,インコーポレイテッド | Muc1による細胞増殖調節方法 |
PL1622648T3 (pl) * | 2003-03-24 | 2010-11-30 | Scripps Research Inst | Szczepionki DNA przeciwko wzrostowi nowotworów i sposoby ich stosowania |
US7696306B2 (en) | 2003-07-11 | 2010-04-13 | Board of Agents of the University of Nebraska | Compositions and methods for preventing or treating cancer |
WO2005042573A1 (en) * | 2003-10-24 | 2005-05-12 | Dana-Farber Cancer Institute, Inc. | Modulation of the interaction of muc1 with muc1 ligands |
US7871784B2 (en) | 2007-02-02 | 2011-01-18 | Dana-Farber Cancer Institute, Inc. | Methods and compositions relating to the regulation of apoptosis by MUC1 and BH3-containing proapoptotic proteins |
US7972870B2 (en) | 2007-02-02 | 2011-07-05 | Dana-Farber Cancer Institute, Inc. | Methods and compositions relating to the regulation of MUC1 by HSF1 and STAT3 |
CN106279435B (zh) * | 2016-08-16 | 2019-06-07 | 新乡医学院 | 靶向VEGF与mucin1的抗肿瘤疫苗、编码基因、表达载体、表达工程菌及应用 |
CN114230656A (zh) * | 2021-03-24 | 2022-03-25 | 深圳市新靶向生物科技有限公司 | 一种与食道癌驱动基因突变相关的抗原肽组合及其应用 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1262545B (it) * | 1993-10-25 | 1996-07-02 | Menarini Ricerche Sud S P A A | Sistema di espressione per linee cellulari eucariotiche |
AU727308B2 (en) * | 1997-02-24 | 2000-12-07 | Dana-Farber Cancer Institute | Recombinant pox virus for immunization against muc1 tumor-associated antigen |
-
1998
- 1998-10-30 IT IT1998MI002330A patent/IT1303683B1/it active
-
1999
- 1999-10-18 AU AU11522/00A patent/AU1152200A/en not_active Abandoned
- 1999-10-18 CZ CZ20011521A patent/CZ20011521A3/cs unknown
- 1999-10-18 WO PCT/EP1999/007874 patent/WO2000025827A2/en not_active Application Discontinuation
- 1999-10-18 BR BR9914892-7A patent/BR9914892A/pt not_active IP Right Cessation
- 1999-10-18 CA CA002348745A patent/CA2348745A1/en not_active Abandoned
- 1999-10-18 CN CN99812745A patent/CN1324406A/zh active Pending
- 1999-10-18 JP JP2000579265A patent/JP2002528519A/ja active Pending
- 1999-10-18 TR TR2001/01141T patent/TR200101141T2/xx unknown
- 1999-10-18 PL PL99348156A patent/PL348156A1/xx unknown
- 1999-10-18 MX MXPA01004186A patent/MXPA01004186A/es unknown
- 1999-10-18 HU HU0103784A patent/HUP0103784A2/hu unknown
- 1999-10-18 EA EA200100395A patent/EA200100395A1/ru unknown
- 1999-10-18 SK SK571-2001A patent/SK5712001A3/sk unknown
- 1999-10-18 EP EP99971329A patent/EP1124956A2/en not_active Withdrawn
- 1999-10-21 AR ARP990105316A patent/AR020927A1/es unknown
- 1999-10-22 PE PE1999001068A patent/PE20001287A1/es not_active Application Discontinuation
- 1999-10-29 CO CO99068636A patent/CO5231134A1/es not_active Application Discontinuation
-
2001
- 2001-04-20 BG BG105458A patent/BG105458A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
BR9914892A (pt) | 2001-07-17 |
CO5231134A1 (es) | 2002-12-27 |
BG105458A (en) | 2002-06-28 |
ITMI982330A0 (it) | 1998-10-30 |
WO2000025827A3 (en) | 2000-08-10 |
AU1152200A (en) | 2000-05-22 |
HUP0103784A2 (hu) | 2002-02-28 |
PE20001287A1 (es) | 2000-12-07 |
TR200101141T2 (tr) | 2001-09-21 |
EP1124956A2 (en) | 2001-08-22 |
WO2000025827A2 (en) | 2000-05-11 |
MXPA01004186A (es) | 2002-06-04 |
ITMI982330A1 (it) | 2000-04-30 |
CN1324406A (zh) | 2001-11-28 |
CZ20011521A3 (cs) | 2001-10-17 |
CA2348745A1 (en) | 2000-05-11 |
EA200100395A1 (ru) | 2001-10-22 |
AR020927A1 (es) | 2002-06-05 |
JP2002528519A (ja) | 2002-09-03 |
SK5712001A3 (en) | 2002-04-04 |
IT1303683B1 (it) | 2001-02-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200110161B (en) | Anti-avB3 recombinant human antibodies, nucleic acids encoding same and methods of use. | |
HUP0001930A3 (en) | Modified tnfalpha molecules, dna encoding such modified tnfalpha molecules and vaccines comprising such modified tnfalpha molecules and dna | |
IL112453A0 (en) | Human repair proteins, dna(rna) encoding them and their preparation | |
PL348156A1 (en) | Pharmaceutical composition, containing fragments of an antigenic protein encoding dna endowed with anti-tumor effect | |
AU7072896A (en) | Dna encoding medicinal proteins | |
AU2003247537A1 (en) | Chd5 encoding nucleic acids, polypeptides, antibodies and methods of use thereof | |
AU3670395A (en) | Hippocampus-associated proteins, dna sequences coding therefor and uses thereof | |
AU1183200A (en) | Novel gene encoding brain-specific membrane protein | |
EP1220896A4 (en) | NEW HUMANE LIPASE PROTEINS, FOR CODING NUCLEIC ACIDS AND THEIR USE | |
AU4157002A (en) | Novel human proteins, polynucleotides encoding them and methods of using the same | |
AU6181500A (en) | Gene encoding novel tsp1-like protein | |
EP1174503A4 (en) | NOVEL PROTEINS, GENES ENCODING THEM AND METHODS OF USE | |
EP1142999A4 (en) | PROTEIN AND ITS DNA | |
EP1111047A4 (en) | NEW PROTEIN AND ITS DNA | |
EP1409004A4 (en) | ISOLATED HUMAN, RAIS-SIMILAR PROTEINS, THESE HUMAN, RAS-SIMILAR PROTEIN-CODING NUCLEIC ACID MOLECULES, AND USES THEREOF | |
AU2002250273A1 (en) | Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof | |
GB9824569D0 (en) | Virulence gene and protein,and their use | |
EP1331268A4 (en) | NOVEL PROTEINS, GENES ENCODING THESE PROTEINS AND THEIR USE | |
ZA200007318B (en) | Particles of HCV envelope proteins: use for vaccination. | |
AU1183100A (en) | Novel ubiquitin-like protein | |
AU2001288218A1 (en) | Isolated human ion channel proteins, nucleic acid molecules encoding them, and uses thereof | |
AU2002250348A1 (en) | Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof | |
AU2002250459A1 (en) | Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof | |
IL161944A0 (en) | Dna sequence, proteins coded by them, medicaments and detection methods using same | |
IL125971A0 (en) | Polypeptides dna molecules encoding them and pharmaceutical compositions |